ANDREY TSYGANOV: RUSSIA’S PRINCIPLE OF USING PRICES IN THE REFERNECE COUNTRIES CORRESPONDS BEST PRACTICES OF PRICE REGULATION

03-12-2018 | 14:27

Speaking at OECD Competition Committee in Paris, Deputy Head of FAS discussed a set of FAS measures towards reducing the maximum ex-works manufacturer prices registered in Russia for medicine to the minimum prices in the reference countries for Russia

 

On 28 November 2018, the Competition Committee of the organization for Economic Cooperation and Development (OECD) held the Round Table on “Excessive pricing in the pharmaceutical sector”.

 

Deputy Head of FAS reported that one of major requirement in force since 2010 is setting prices in Russia in line with the minimum level of prices for the same medicines in the reference countries for Russia.

 

FAS carried out an international comparative price analysis and found that prices for some medicines in Russia were considerably higher in comparison with the minimum ex-works prices in many countries of the world, particularly, the reference countries for Russia.

 

“Thanks to the measures under taken by FAS, prices for more than 1000 early registered, expensive vital and essential medicines were reduced significantly, which saved more than 5 billion RUB budgetary funds”, informed Andrey Tsyganov.

 

As a result of the survey, FAS identified countries with sustainably high or low levels of medicine prices.

 

Due to the above, a Decree of the Government of the Russian Federation is drafted obligating owners or holders of medicine registration certificates to review the registered medicine prices in case their reduction in the reference countries.

 

“In other countries the practice of using price information of other countries is widely popular in the global experience of medicine price regulation.  FAS analyzed the European experience of applying external price regulation and concluded that the current principle of using prices in the reference countries conforms to the European practice of prices of regulation as well as the positive experience of considerable price reduction in Russia for expensive medicines”, concluded Deputy Head of FAS.



Site Map

News & Events Press Releases Media Releases Image Library About the FAS Russia What We Do General Information Mission, Goals, Values Priority Setting Institutional Memory Stakeholders Engagement Center for Education and Methodics Our History Our Structure Powers of Head and Deputy Heads Our Ratings GCR Using our website International Cooperation Treaties & Agreements International Working Groups Working Group on Research of Competition Issues in the Market of International Telecommunications (Roaming) Meetings Working Group for Studying Competition Problems in the Pharmaceutical Sector Concept Note Meetings OECD Competition Committee OECD meetings 2013 OECD meetings 2014 OECD meetings 2015 OECD meetings 2016 OECD meetings 2017 OECD meetings 2018 FAS Annual Reports OECD-GVH RCC RCC Newsletter ICAP Council on Advertising Headquarters for Joint Investigations UNCTAD 13th session IGE UNCTAD Resolution Russian contributions 14th session IGE UNCTAD Resolution Russian contributions 15th session IGE UNCTAD 16th session IGE UNCTAD 17th session IGE UNCTAD EEU Model Law on Competition ICN BRICS WG (Markets of Social Importance) EU APEC Competition Policy and Law Group Annual meetings Projects ERRA Full Members Organizational Structure Archive Working Group on Investigating Issues on Pricing in the Oil and Oil Product Markets and Methods of their Functioning Meetings Document Library Legislation Reports & Analytics Cases & decisions Contacts Give feedback Contact us Links Authorities Worldwide